Form 4: Gevo VP Davaajargal Receives Equity Grant
Statement of Changes in Beneficial Ownership
Gevo, Inc. VP of Accounting and Treasurer Gendenjamts Davaajargal was granted 52,941 restricted shares and 61,169 stock options.
Summary
- Gendenjamts Davaajargal, VP of Accounting and Treasurer at Gevo, Inc., received a grant of 52,941 shares of restricted common stock.
- The reporting person was also granted 61,169 stock options with an exercise price of $1.64 per share.
- Both the restricted stock and the stock options vest in three equal annual installments starting on the first anniversary of the grant date, contingent on continued service.
- The reporting person also updated their 401(k) holdings, reflecting a net increase of 5,804.86 shares between December 2025 and May 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral for the stock price.
Positives
- Alignment of management interests with shareholders through equity-based compensation.
- Continued accumulation of company stock by a key financial officer via the 401(k) plan.
Negatives
- The issuance of new equity and options results in potential future dilution for existing shareholders.
Risks
- Vesting is contingent upon the reporting person remaining in continuous service with the issuer.
- Stock options are subject to market price fluctuations relative to the $1.64 exercise price.
Future Outlook
The equity grants are subject to a three-year vesting schedule, indicating a long-term retention strategy for the reporting officer.
Industry Context
StockSavvy.ai notes that equity grants to financial executives are standard corporate governance practices intended to incentivize long-term performance and retention in the volatile biofuels and renewable chemicals sector.
Comparison to Industry Standards
- The use of three-year vesting schedules for executive equity is consistent with standard compensation practices for mid-cap growth companies.
- The inclusion of stock options with a set exercise price aligns with typical incentive structures for officers in the energy technology industry.
Stakeholder Impact
- Shareholders may experience minor dilution from the issuance of new equity.
Next Steps
- Vesting of the first installment of restricted stock and options on May 20, 2027.
Key Dates
| Date | Description |
|---|---|
| 12/04/2025 | Start of 401(k) plan transaction period |
| 04/22/2026 | Date of 401(k) plan statement |
| 05/20/2026 | Date of equity grant and transaction |
| 05/22/2026 | Filing date of Form 4 |
| 05/19/2036 | Expiration date of stock options |
Keywords
Gevo, GEVO, Insider Trading, Form 4, Equity Compensation, Stock Options, Restricted Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.